BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4408104)

  • 21. Vitamin K requirement and warfarin tolerance in the hamster.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):126-8. PubMed ID: 1187683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation.
    De Curtis A; D'Adamo MC; Amore C; Polishchuck R; Castelnuovo AD; Donati MB; Iacoviello L
    Thromb Haemost; 2001 Dec; 86(6):1440-8. PubMed ID: 11776312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.
    Chan E; Aarons L; Serlin M; Breckenridge A; Rowland M
    Br J Clin Pharmacol; 1987 Nov; 24(5):621-5. PubMed ID: 3435692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolongation by warfarin of "template" bleeding time in rats: a vitamin K-dependent effect.
    Reyers I; de Gaetano G; Donati MB
    Proc Soc Exp Biol Med; 1986 Feb; 181(2):275-6. PubMed ID: 3945636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potentiation of warfarin anticoagulation by amiodarone.
    Hamer A; Peter T; Mandel WJ; Scheinman MM; Weiss D
    Circulation; 1982 May; 65(5):1025-9. PubMed ID: 7074739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease.
    Goldschmidt B
    Acta Paediatr Acad Sci Hung; 1970; 11(2):135-9. PubMed ID: 5504583
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the control of anticoagulant therapy.
    Owren PA
    Geriatrics; 1971 Aug; 26(8):74 passim. PubMed ID: 5096463
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanism of action of vitamin K and how it is affected by anticoagulants].
    Schade R; Janowski K
    Pharmazie; 1976; 31(9):585-9. PubMed ID: 798207
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of hyperthyroidism on hypoprothrombinemic response to warfarin.
    Self TH; Straughn AB; Weisburst MR
    Am J Hosp Pharm; 1976 Apr; 33(4):387-9. PubMed ID: 1266879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The challenge of regulating anticoagulant drugs: focus on warfarin.
    Mann KG
    Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
    [No Abstract]   [Full Text] [Related]  

  • 32. Potency and coagulation factor effects of 2,3,5,6-tetrachloro-4-pyridinol compared to warfarin and its antagonism by vitamin K.
    Marshall FN
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):806-10. PubMed ID: 5023769
    [No Abstract]   [Full Text] [Related]  

  • 33. Warfarin and the inhibition of vitamin K activity by an oxide metabolite.
    Bell RG; Matschiner JT
    Nature; 1972 May; 237(5349):32-3. PubMed ID: 4555434
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rodenticidal activity of warfarin. 2. Kinetics].
    Niedner R; Kayser M; Meyer F
    Arzneimittelforschung; 1974 Jun; 24(6):522-4. PubMed ID: 4408102
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on experimentally induced hypercoagulable state in rabbits.
    Izak G; Galewsky K
    Thromb Diath Haemorrh; 1966 Jul; 16(1):228-42. PubMed ID: 5989043
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of warfarin sodim on the duration of platelet aggregation.
    Knieriem HJ; Chandler AB
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):766-78. PubMed ID: 5590256
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of clotting factor biosynthesis by vitamin K.
    Suttie JW
    Fed Proc; 1969; 28(5):1696-701. PubMed ID: 4897771
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitamin K and warfarin. Metabolism, function and interaction.
    Woolf IL; Babior BM
    Am J Med; 1972 Sep; 53(3):261-7. PubMed ID: 5054720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.